Vireo Growth has reached a deal to acquire certain retail assets and properties of PharmaCann in Colorado. The deal for 17 dispensaries, which will expand Vireo’s position in Colorado’s adult-use retail market to 41 retail locations, is valued at approximately $49 million.
The deal also covers PharmaCann's licenses in the state as well as inventory, contracts, and intellectual property, including certain marks associated with the LivWell brand.
The companies said the transaction is expected to close during the first half of 2026. They have a management services agreement in place that will allow Vireo to participate in operations until the deal closes.
“We are pleased to announce this transaction which reflects the continuation of our strategy to continue growing our business through accretive M&A. This transaction will complement our other recently acquired assets in Colorado," said Vireo CEO Jan Mazarakis in a statement.
